Samsung Biologics has a total of 282 patents globally, out of which 135 have been granted. Of these 282 patents, more than 74% patents are active. Korea (South) is where Samsung Biologics has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, Korea (South) seems to be the main focused R&D centre and also is the origin country of Samsung Biologics.
Samsung Biologics was founded in 2011. Samsung Biologics is a contract development and manufacturing organization (CDMO) that supports pharmaceutical and biotech companies in developing and manufacturing biologic drugs. It provides services such as cell line development, process development, and clinical and commercial manufacturing. The company works with global clients and follows international quality and regulatory standards.
Samsung Biologics has also expanded its U.S. manufacturing presence by acquiring a biologics facility from GSK, helping it support customers in the U.S. market.
Do read about some of the most popular patents of Samsung Biologics which have been covered by us in this article and also you can find Samsung Biologics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Samsung Biologics patent portfolio.
How many patents does Samsung Biologics have?
Samsung Biologics has a total of 282 patents globally. These patents belong to 82 unique patent families. Out of 282 patents, 210 patents are active.
How Many Patents did Samsung Biologics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Samsung Biologics Applications Filed | Samsung Biologics Patents Granted |
| 2025 | 3 | 13 |
| 2024 | 14 | 12 |
| 2023 | 18 | 9 |
| 2022 | 12 | 4 |
| 2021 | 37 | 27 |
| 2020 | 34 | 20 |
| 2019 | 43 | 21 |
| 2018 | 30 | 29 |
| 2017 | 56 | – |
| 2016 | 10 | – |
| 2015 | 14 | – |
| 2014 | 11 | – |
How many Samsung Biologics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Samsung Biologics File in Different Countries?
Countries in which Samsung Biologics Filed Patents
| Country | Patents |
| Korea (South) | 67 |
| United States of America | 34 |
| Europe (EPO) | 29 |
| Australia | 24 |
| Canada | 17 |
| Brazil | 11 |
| Japan | 11 |
| United Kingdom | 9 |
| China | 9 |
| Taiwan | 7 |
| New Zealand | 6 |
| Germany | 4 |
| Hong Kong (S.A.R.) | 3 |
| Israel | 2 |
| Austria | 2 |
| Denmark | 2 |
| Poland | 1 |
| Singapore | 1 |
| Saudi Arabia | 1 |
| Russia | 1 |
Where are Research Centers of Samsung Biologics Patents Located?
10 Best Samsung Biologics Patents
USD867583S1 is the most popular patent in the Samsung Biologics portfolio. It has received 37 citations so far from companies like Fisher & Paykel Healthcare, Nissho Chugai Pharmaceutical, Teoxane.
Below is the list of 10 most cited patents of Samsung Biologics:
| Publication Number | Citation Count |
| USD867583S1 | 37 |
| USD904879S1 | 13 |
| KR1020210097882A | 9 |
| USD904878S1 | 9 |
| WO2020055123A1 | 8 |
| WO2019124946A1 | 8 |
| USD833603S1 | 8 |
| WO2021118321A1 | 7 |
| WO2020060192A1 | 6 |
| USD855451S1 | 6 |
What are Samsung Biologics key innovation segments?
What Technologies are Covered by Samsung Biologics?
The chart below distributes patents filed by Samsung Biologics in different countries on the basis of the technology protected in patents. It also represents the markets where Samsung Biologics thinks it’s important to protect particular technological inventions.
R&D Focus: How has Samsung Biologics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Samsung Biologics?
